This article has been cited by
1Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program
Dariga S. Smailova,Elisa Fabbro,Serik E. Ibrayev,Luca Brusati,Yuliya M. Semenova,Umutzhan S. Samarova,Farida S. Rakhimzhanova,Sabit M. Zhussupov,Zaituna A. Khismetova,Hengameh Hosseini
Prostate Cancer.2020;2020()1
[DOI]
2Analytical and Clinical Assessment of Prostate Specific Antigen Using an HISCL-5000 Chemiluminescence Immunoassay
Jayho Han,Dong Wook Jekarl,Seungok Lee,Myungshin Kim,Yonggoo Kim
Laboratory Medicine Online.2022;12(1)26
[DOI]
3Significance of PSA Screening in Niigata, Japan: Survey of Actual Status of New Cases of Prostate Cancer
Toshihiro Saito,Shuichi Komatsubara,Noboru Hara,Tsutomu Nishiyama,Akiyoshi Katagiri,Fumio Ishizaki,Akihiko Hatano,Takeshi Komeyama,Shugo Hanyu,Masahiro Terunuma,Tomoyuki Imai,Hideto Go,Hiroaki Iida,Shigenori Kurumada,Shunsuke Yamaguchi,Keisuke Takeda,Takashi Ando,Tatsuhiko Hoshii,Takashi Kasahara,Yoshihiko Tomita
Research and Reports in Urology.2021;Volume 13(1)859
[DOI]
4Prostate Cancer Screening with PSA: Ten Years’ Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania
Ausvydas Patasius,Agne Krilaviciute,Giedre Smailyte
Journal of Clinical Medicine.2020;9(12)3826
[DOI]
5Risk of Prostate Cancer Incidence among Atomic Bomb Survivors: 1958–2009
Kiyohiko Mabuchi,Dale L. Preston,Alina V. Brenner,Hiromi Sugiyama,Mai Utada,Ritsu Sakata,Atsuko Sadakane,Eric J. Grant,Benjamin French,Elizabeth K. Cahoon,Kotaro Ozasa
Radiation Research.2020;195(1)3826
[DOI]
6HPV genotype prevalence and distribution during 2009–2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination
Jing Wang,Dandan Tang,Kai Wang,Jialu Wang,Zhaoxia Zhang,Yanxia Chen,Xueliang Zhang,Cailing Ma
BMC Women's Health.2019;19(1)3826
[DOI]
Feedback

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal